New research seeks to improve survival for myeloma and lymphoma patients

August 2012
Biomedical Market Newsletter;8/1/2012, Vol. 21, p1
The article presents information on the research regarding the improvement in the survival of patients suffering from myeloma and lymphoma.


Related Articles

  • A 30-year epidemiologic survey (1974-2003) of haematological malignancies on the island of Sardinia: temporal changes in incidence and a geographic comparison of incidence rates. Broccia, G.; Longinotti, M.; Gabbas, A.; Porcu, Caterina; Chessa, E.; Giannico, Barbara // Annals of Hematology;Jun2014, Vol. 93 Issue 6, p1041 

    In a previous survey of newly diagnosed haematological malignancies (HMs) in Sardinia from 1974 to 1993, we observed a marked increase in the incidence of many HMs that we chiefly attributed to improvements in case ascertainment. To better define the nature of this increase, we extended the...

  • Rectal Carcinoma Case Causing Bicytopenia. Cifci, Sami; Bilgin, Aynur Ugur; Biyik, Murat; Ataseven, Huseyin; Toy, Hatice // World Journal of Oncology;2014, Vol. 5 Issue 1, p52 

    Although conditions leading to bicytopenia and pancytopenia secondary to infiltrative diseases of the bone marrow are seen, a profound anemia or hemorrhages are frequently observed in such cases. As bone marrow infiltrations may be associated with primary hematological diseases such as leukemia,...

  • Intramuscular plasmacytoma. Surov, Alexey; Tcherkes, Anatolij; Meier, Frieder // Skeletal Radiology;Nov2014, Vol. 43 Issue 11, p1561 

    Objective: In multiple myeloma, secondary infiltration of adjacent muscles from bone lesions is common. However, plasmacytoma directly arising within the skeletal musculature is rare. Imaging findings of this rare entity have been described only sporadically. The purpose of this study was to...

  • Syndecan-1 in B lymphoid malignancies. Sanderson, R. D.; Børset, M. // Annals of Hematology;Mar2002, Vol. 81 Issue 3, p125 

    Syndecans are heparan sulfate-bearing proteoglycans that are found on the surface of most cells. Syndecan-1 is expressed predominantly on epithelia, but is also present on pre-B cells and plasma cells. The syndecans act to bind various effector molecules via their heparan sulfate chains,...

  • Bone marrow transplantation may augment cardiac systolic function in patients with a reduced left ventricular ejection fraction. Piranfar, Mohammad A.; Karvandi, Mersedeh; Yazdani, Shahrooz; Pishgahi, Mehdi; Mehdizadeh, Mahshid; Hajfathali, Abbas; Tabarraee, Mehdi // Journal of Cardiovascular Disease Research (Medknow Publications;Oct-Dec2012, Vol. 3 Issue 4, p310 

    Introduction: Cardiac function is influenced by bone marrow transplantation (BMT). Studies have shown the various cardiotoxic effects of high-dose chemotherapy. In this study, we aimed to determine the effects of BMT on cardiac systolic function using echocardiographic indices. Materials and...

  • Rheumatic manifestations of hematologic malignancies: Correlation with laboratory markers. Kamel, Shereen R.; Abdel-Nasser, Ahmed M.; Mohamed, Mervat M. // Journal of Hematological Malignancies;Dec2011, Vol. 1 Issue 1, p15 

    Objective: To determine the rheumatic manifestations associated with hematologic malignancies namely acute and chronic leukemia, Hodgkin's and non-Hodgkin's lymphomas, and multiple myeloma; and the markers correlating with their presence. Methods: Eighty patients with hematologic malignancies...

  • Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat. Dholaria, Bhagirathbhai; Alapat, Daisy; Pandey, Tarun; Agarwal, Abhishek // Medical Oncology;Dec2012, Vol. 29 Issue 5, p3529 

    Plasmablastic lymphoma (PBL) is an aggressive diffuse large B-cell lymphoma (DLBCL) with plasmablastic features that was initially described in the oral cavity of HIV-infected individuals. PBL remains a diagnostic challenge given its close morphologic resemblance and overlapping immunophenotypic...

  • Arrhythmias in the setting of hematopoietic cell transplants. Tonorezos, E S; Stillwell, E E; Calloway, J J; Glew, T; Wessler, J D; Rebolledo, B J; Pham, A; Steingart, R M; Lazarus, H; Gale, R P; Jakubowski, A A; Schaffer, W L // Bone Marrow Transplantation;Sep2015, Vol. 50 Issue 9, p1212 

    Prior studies report that 9-27% of persons receiving a hematopoietic cell transplant develop arrhythmias, but the effect on outcomes is largely unknown. We reviewed data from 1177 consecutive patients ⩾40 years old receiving a hematopoietic cell transplant at one center during 1999-2009....

  • Immunomodulating antibodies and drugs for the treatment of hematological malignancies. Houot, Roch; Kohrt, Holbrook; Goldstein, Matthew; Levy, Ronald // Cancer & Metastasis Reviews;Mar2011, Vol. 30 Issue 1, p97 

    The aim of cancer immunotherapy is to induce immune cells to kill tumor and promote immunological memory that protects against tumor recurrence. Most current immunotherapies, such as monoclonal antibodies (mAb), target the tumor cells directly. Advances in our understanding of the immune system...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics